In established atherosclerosis, cholesterol lowering alone is insufficient to promote plaque regression, as monocyte-specific netrin-1 impairs the reorganization of the plaque’s immune cell landscape and hinders monocyte egress [100]. The gene discussed is NTN1; the disease is atherosclerosis.